Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Reveals New Customers

NEW YORK, Dec 11 - Compugen revealed Monday a host of new companies that recently signed on as customers of its products and services.

A Compugen spokeswoman said that “over the past few months” AlphaGene, Avalon Pharmaceuticals, Aventis Pharmaceuticals, Chugai Biopharmaceuticals, Scios, and Serono had all become customers of either its LabOnWeb portal, its full-gene-structure reports, or its custom-tailored analysis services.

In addition, Motorola recently announced that it would use Compugen’s chip design services in the development and manufacture of some of its DNA biochips.

On Monday Compugen, which is based in Jamesburg, NJ, and Tel Aviv, also announced the opening of a business development, sales and marketing office in Sunnyvale, California. GenomeWeb first reported the planned opening of the facility last month.

The new site will be used as a launch pad for sales of Compugen's genomic and proteomic products on the West Coast.

“Being closer to our customers will enhance our ability to provide our solutions to our customers," Eli Mintz, president of Compugen, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more